Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 14;84(3):635-42.
doi: 10.1128/IAI.01263-15.

The C-Type Lectin Receptor MCL Mediates Vaccine-Induced Immunity against Infection with Blastomyces dermatitidis

Affiliations

The C-Type Lectin Receptor MCL Mediates Vaccine-Induced Immunity against Infection with Blastomyces dermatitidis

Huafeng Wang et al. Infect Immun. .

Abstract

C-type lectin receptors (CLRs) are essential in shaping the immune response to fungal pathogens. Vaccine-induced resistance requires Dectin-2 to promote differentiation of antifungal Th1 and Th17 cells. Since Dectin-2 and MCL heterodimerize and both CLRs use FcRγ as the signaling adaptor, we investigated the role of MCL in vaccine immunity to the fungal pathogen Blastomyces dermatitidis. MCL(-/-) mice showed impaired vaccine resistance against B. dermatitidis infection compared to that of wild-type animals. The lack of resistance correlated with the reduced recruitment of Th17 cells to the lung upon recall following experimental challenge and impaired interleukin-17 (IL-17) production by vaccine antigen-stimulated splenocytes in vitro. Soluble MCL fusion protein recognized and bound a water-soluble ligand from the cell wall of vaccine yeast, but the addition of soluble Dectin-2 fusion protein did not augment ligand recognition by MCL. Taken together, our data indicate that MCL regulates the development of vaccine-induced Th17 cells and protective immunity against lethal experimental infection with B. dermatitidis.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Vaccine-induced immunity against B. dermatitidis requires MCL signaling. MCL−/− mice and wild-type littermates were vaccinated with 106 live vaccine yeast twice over the course of 4 weeks. Two weeks after the boost, vaccinated and unvaccinated mice were challenged with 2 × 103 wild-type yeast. At 2 weeks postinfection (A), when unvaccinated mice were moribund, or 4 days postinfection (B), during the peak influx of antigen-specific CD4 T cells into the lung, lung CFU were assessed. Data are the means ± standard errors of the means (SEM) (n = 8 to 12 mice/group); data are from a single experiment representative of 3 independent experiments. *, P < 0.05 versus vaccine-induced reduction in lung CFU in wild-type mice. Numbers indicate the n-fold difference in lung CFU versus that of unvaccinated controls.
FIG 2
FIG 2
Number of activated T cells migrating to the lung on recall is reduced in MCL−/− mice. MCL−/− mice and wild-type littermates received an adoptive transfer of 106 CD4+ purified, naive 1807 Tg cells and were vaccinated with 106 live vaccine yeast or left unvaccinated. At day 4 postinfection, the number of activated (CD44+) transferred 1807 T cells was enumerated from the lung by flow cytometry. (A and B) Dot plots show concatenated samples of 4 to 6 mice/group. The numbers indicate the means ± SEM of activated (CD44hi) 1807 Tg (Thy1.1+) T cells. Data are expressed as means ± SEM (n = 4 to 6 mice/group). Data are means ± SEM (n = 4 to 6 mice/group) from single experiments representative of 3 independent experiments. *, P < 0.05 versus the number of 1807 T cells in vaccinated wild-type mice.
FIG 3
FIG 3
Number of IL-17-producing T cells migrating to the lung on recall is reduced in MCL−/− mice. MCL−/− mice and wild-type littermates received an adoptive transfer of 106 CD4+ purified, naive 1807 Tg cells and were vaccinated with 106 live vaccine yeast cells or left unvaccinated. At day 4 postinfection, the number and frequency of cytokines producing 1807 T cells were enumerated from the lung by FACS. (A to C) Dot plots show concatenated samples of 4 to 6 mice/group. The numbers inside the dot plots indicate the mean number ± SEM of IFN-γ- and IL-17-producing 1807 Tg (Thy1.1+) T cells. The numbers outside the dot plots indicate the mean frequencies ± SEM of IFN-γ- and IL-17-producing 1807 Tg (Thy1.1+) T cells. Data are expressed as the means ± SEM (n = 4 to 6 mice/group). *, P < 0.05 versus cytokine production by T cells from wild-type mice. (D) At day 4 postinfection, the splenocytes were stimulated with CW/M Ag and IFN-γ and IL-17 production was determined by ELISA. Data are the means ± SEM (n = 4 to 6 mice/group) from single experiments representative of 3 independent experiments. *, P < 0.05 versus the number of lung CFU from vaccinated wild-type mice.
FIG 4
FIG 4
MCL and Dectin-2 regulate T-cell expansion and Th17 cell differentiation. C57BL6 wild-type mice (Dectin-2+/+), Dectin-2−/− mice, and MCL−/− mice and wild-type littermates received an adoptive transfer of 106 CD4+ purified, naive, CFSE-labeled 1807 Tg cells and were vaccinated with 106 live vaccine yeast or left unvaccinated. At day 8 postvaccination, the number of activated (CD44+) (A) and cytokine-producing (B) 1807 T cells were enumerated from the lung by FACS. Dot plots show concatenated samples of 4 to 6 mice/group. The numbers inside the dot plots indicate the mean number ± SEM of activated (CD44+) 1807 Tg (Thy1.1+) T cells. Data are expressed as the means ± SEM (n = 4 to 6 mice/group). *, P < 0.05 versus activated 1807 T cells from wild-type mice. SP, spleen. (C) T cells from the sdLN and spleen were stimulated with CW/M antigen for 3 days, and cytokines were measured in the cell culture supernatant. *, P < 0.05 versus cytokines from wild-type control mice.
FIG 5
FIG 5
Recognition of B. dermatitidis ligands by Dectin-2 and MCL. (A and B) B3Z cells expressing FcRγ, Dectin-2 and FcRγ, MCL and FcRγ, or Dectin-2, MCL, and FcRγ were stimulated with heat-killed B. dermatitidis (A) or plate-coated cell wall extract (CWE) isolated from live and heat-killed B. dermatitidis (B). After 18 h, lacZ activity was measured using a colorimetric assay and expressed as OD560/OD620 values. Data are the means ± standard deviations from duplicate wells. (C) Recombinant human IgG1 Fc, Dectin-2-Fc, MCL-Fc, and a mixture (1:1) of Dectin-2-Fc and MCL-Fc were incubated with the indicated amount of plate-coated cell wall extract isolated from live or heat-killed B. dermatitidis. Bound proteins were detected with anti-hIgG-HRP and expressed as OD450 values. (D) Fc protein staining of B. dermatitis. Heat-killed and live yeast cells were incubated with Fc fragment alone, Dectin-2-Fc, MCL-Fc, or a mixture of Dectin-2-Fc and MCL-Fc, as indicated by different colors, followed by staining with PE-conjugated anti-human Fc Ab and analysis by FACS. As a negative control, Ab-stained fungal cells without any Fc proteins are indicated by gray filled histograms.

References

    1. Verma A, Wüthrich M, Deepe G, Klein B. 2015. Adaptive immunity to fungi. Cold Spring Harb Perspect Med 5:a019612. doi:10.1101/cshperspect.a019612. - DOI - PMC - PubMed
    1. Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE Jr, Hennessey JP Jr. 2012. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30:7594–7600. doi:10.1016/j.vaccine.2012.10.038. - DOI - PMC - PubMed
    1. Wüthrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J, Galles K, Filutowicz H, Warner T, Evans M, Cole G, Klein B. 2011. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Investig 121:554–568. doi:10.1172/JCI43984. - DOI - PMC - PubMed
    1. Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, Fu Y, French SW, Edwards JE Jr, Spellberg B. 2009. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5:e1000703. doi:10.1371/journal.ppat.1000703. - DOI - PMC - PubMed
    1. Wüthrich M, Filutowicz HI, Warner T, Klein BS. 2002. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 169:6969–6976. doi:10.4049/jimmunol.169.12.6969. - DOI - PubMed

Publication types

LinkOut - more resources